Evidence map›Paper›PMID 34615340›Full record

ArticleHaematologica2022

Signal transduction pathway involved in platelet activation in immune thrombotic thrombocytopenia after COVID-19 vaccination.

Roberta Misasi, Antonella Capozzi, Gloria Riitano, Serena Recalchi, Valeria Manganelli, Vincenzo Mattei, Agostina Longo, Manuela De Michele, Tina Garofalo, Fabio M Pulcinelli and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roberta MisasiDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Antonella CapozziDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Gloria RiitanoDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Serena RecalchiDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Valeria ManganelliDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Vincenzo MatteiBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100, Rieti.
Agostina LongoDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Manuela De MicheleEmergency Department, "Sapienza" University of Rome, 00161 Rome.
Tina GarofaloDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Fabio M PulcinelliDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome.
Maurizio SoriceDepartment of Experimental Medicine, "Sapienza" University of Rome, 00161 Rome. maurizio.sorice@uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19ThrombocytopeniaCOVID-19 VaccinesHumansPlatelet ActivationSARS-CoV-2Signal TransductionVaccinationCOVID-19 Vaccines

Identifiers

PMID34615340
PMCPMC8719068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.